ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3226

Increased Serum Levels of IgG Antibodies Against to Alpha-Enolase Are Associated with Severity of Oral Ulcers in Patients with Behcet’s Disease

Shin Eui Kang1, Sang Jin Lee2,3, Jin Kyun Park2,4, Joo Youn Lee2, Eun Young Lee3, Eun Bong Lee3 and Yeong Wook Song3,5, 1Department of Molecular Medicine and Biopharmaceutical Sciences, BK 21 plus Graduate School of Convergence Science and Technology, and College of Medicine or College of Parmarcy, Seoul National University, Seoul, South Korea, 2Department of Molecular Medicine and Biopharmaceutical Sciences, BK21 plus Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul National University, Seoul, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea, 4Department of Molecular Medicine and Biopharmaceutical Sciences Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy Seoul National University, Seoul, South Korea, 5Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine Seoul National University, Seoul, South Korea

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Behcet's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Vasculitis IV

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

Behcet’s
Disease (BD) is a chronic inflammatory disease characterized by recurrent oral
and genital ulcers, skin lesions, uveitis, and arthritis. Although the etiology
of BD still remains to be elucidated, several autoantibodies including
anti-alpha-enolase (ENO1) antibodies (AEA) have been associated with BD. AEA
are directed against endothelial cells and might contribute to vasculitis
leading to subsequent oral ulcer formation. This study was aimed to investigate
the association between AEA and clinical manifestations of BD.

Methods:

In
this study 64 BD patients and 30 age/sex matched healthy controls (HCs) were
enrolled. Western blot with recombinant ENO1 proteins were performed to detect
the presence of AEA in serum from BD patients and HCs. Subsequently, enzyme-linked
immunosorbent assay (ELISA) was performed to determine the serum levels of AEA.
The association between BD manifestation and AEA levels were examined.

Results:

AEA
were present in 14 (82.4%) of 17 BD patients as compared to 6 (66.7%) of 9 HCs
on Western blot. Serum levels of AEA tended to be increased in BD patients
compared to HCs. (Mean ± SE : 1543 ± 160 vs. 1067 ± 144, p=
0.06). Number of oral ulcers tended to correlate with serum levels of AEA (r = 0.238,
p = 0.06 by Spearmann). BD patients with oral ulcers were grouped into a
mild (number of oral ulcer is less than or equal to 2) and a severe (number of
oral ulcer is greater than 2) disease based on the cumulative number of oral
ulcers in the preceding 4 weeks prior to blood sampling. AEA levels differed
between HCs, the BD patients mild and those with extensive oral ulcers (p =
0.04 Kruskal-Wallis). Patients with extensive oral ulcers exhibited significantly
higher levels of AEA than those with mild oral ulcers (1722 ± 178 vs. 1416 ± 257, p =
0.03), and HCs
(1722 ± 178
vs. 1067 ±144, p < 0.01). Skin lesions, uveitis, and arthritis had no association
with serum AEA levels.

Conclusion:

BD
patients with severe oral ulcers have increased serum levels of AEA than those
with mild oral ulcers and HCs, suggesting a possible pathogenic role of AEA in
the oral ulcer formation. A treatment targeting AEA might offer a new
therapeutic option for BD associated severe oral ulcer.

±×¸²1


Disclosure: S. E. Kang, None; S. J. Lee, None; J. K. Park, None; J. Y. Lee, None; E. Y. Lee, None; E. B. Lee, None; Y. W. Song, None.

To cite this abstract in AMA style:

Kang SE, Lee SJ, Park JK, Lee JY, Lee EY, Lee EB, Song YW. Increased Serum Levels of IgG Antibodies Against to Alpha-Enolase Are Associated with Severity of Oral Ulcers in Patients with Behcet’s Disease [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/increased-serum-levels-of-igg-antibodies-against-to-alpha-enolase-are-associated-with-severity-of-oral-ulcers-in-patients-with-behcets-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-serum-levels-of-igg-antibodies-against-to-alpha-enolase-are-associated-with-severity-of-oral-ulcers-in-patients-with-behcets-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology